SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+26.4%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$539M
AUM Growth
+$539M
(+29%)
Cap. Flow
-$97.5M
Cap. Flow
% of AUM
-18.1%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
101
New
24
Increased
17
Reduced
30
Closed
10
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$19.5M |
| 2 |
Nova
NVMI
|
$18.1M |
| 3 |
Global E Online
GLBE
|
$10.7M |
| 4 |
Taboola.com
TBLA
|
$7.47M |
| 5 |
WIX.com
WIX
|
$7.07M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$101M |
| 2 |
Jasper Therapeutics
JSPR
|
$39.2M |
| 3 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$10.3M |
| 4 |
AstraZeneca
AZN
|
$7.07M |
| 5 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$6.35M |
Sector Composition
| 1 | Healthcare | 72.84% |
| 2 | Technology | 18.22% |
| 3 | Communication Services | 4.34% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Utilities | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $25.8M | 4.15% | 2,469,100 +1,869,100 | +312% | +$19.5M |
|
2
Sanofi
SNY
$121B
| $24.8M | 4% | 499,515 | – | – |
|
3
Cytokinetics
CYTK
$4.23B
| $18.7M | 3.01% | 223,820 -10,113 | -4% | -$844K |
|
|
4
Nova
NVMI
$7.74B
| $18.1M | 2.92% | +132,000 | New | +$18.1M |
|
5
Syndax Pharmaceuticals
SNDX
$1.41B
| $16.7M | 2.69% | 772,964 -97 | -0% | -$2.1K |
|
6
Tower Semiconductor
TSEM
$6.58B
| $16.1M | 2.6% | 528,300 +58,726 | +13% | +$1.79M |
|
7
Nice
NICE
$8.73B
| $13.5M | 2.17% | 67,718 +30,236 | +81% | +$6.03M |
|
8
Merck
MRK
$210B
| $13.5M | 2.17% | 123,600 | – | – |
|
9
Celldex Therapeutics
CLDX
$1.47B
| $12.5M | 2.01% | 315,644 +135,644 | +75% | +$5.38M |
|
10
Johnson & Johnson
JNJ
$427B
| $12.5M | 2.01% | 79,831 -15,000 | -16% | -$2.35M |
|
11
Meta Platforms (Facebook)
META
$1.86T
| $12.1M | 1.95% | 34,303 +19,083 | +125% | +$6.75M |
|
|
12
AstraZeneca
AZN
$248B
| $12.1M | 1.95% | 180,060 -105,000 | -37% | -$7.07M |
|
13
Biogen
BIIB
$19.4B
| $12M | 1.93% | 46,346 +20,500 | +79% | +$5.3M |
|
14
BridgeBio Pharma
BBIO
$9.89B
| $11.4M | 1.83% | 282,146 -63,391 | -18% | -$2.56M |
|
|
15
Global E Online
GLBE
$5.68B
| $10.7M | 1.72% | +269,794 | New | +$10.7M |
|
|
FUSN
16
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $10.4M | 1.68% | 1,085,639 -268,619 | -20% | -$2.58M |
|
17
Kura Oncology
KURA
$686M
| $10.1M | 1.63% | 703,287 | – | – |
|
18
Novo Nordisk
NVO
$251B
| $9.63M | 1.55% | 93,080 | – | – |
|
19
Ultragenyx Pharmaceutical
RARE
$2.89B
| $9.61M | 1.55% | 201,044 -58,091 | -22% | -$2.78M |
|
20
Microsoft
MSFT
$3.77T
| $8.97M | 1.44% | 23,848 -10,594 | -31% | -$3.98M |
|
21
Astria Therapeutics
ATXS
$349M
| $8.84M | 1.42% | 1,151,145 +570,546 | +98% | +$4.38M |
|
|
INBX
22
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $8.61M | 1.39% | 226,551 -29,820 | -12% | -$1.13M |
|
23
Amazon
AMZN
$2.44T
| $8.46M | 1.36% | 55,676 -39,624 | -42% | -$6.02M |
|
24
Eli Lilly
LLY
$657B
| $8.27M | 1.33% | 14,190 | – | – |
|
25
Day One Biopharmaceuticals
DAWN
$769M
| $7.49M | 1.21% | 513,000 -17,000 | -3% | -$248K |
|